Antiviral activity of human Vδ2 T-cells against WNV includes both cytolytic and non-cytolytic mechanisms

New Microbiologica

Volumn 39, Issue 2, 2016, Pages 139-142

  Agrati, Chiara ^a,b   Castilletti, Concetta ^b   Cimini, Eleonora ^a   Romanelli, Antonella ^a   Lapa, Daniele ^b   Quartu, Serena ^b   Martini, Federico ^a   Capobianchi, Maria Rosaria ^b  

^a Cellular Immunology Laboratory   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Cytotoxicity; IFN ; Innate immunity; T cells

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;

ANIMAL; CELL LINE; HUMAN; IMMUNOLOGY; MOUSE; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALS; CELL LINE; DIPHOSPHONATES; HUMANS; IMIDAZOLES; MICE; T-LYMPHOCYTE SUBSETS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84971378760     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. (2002a). Laboratory-acquired West Nile virus infections-United States, 2002. MMWR Morb. Mortal. Wkly. Rep. 51, 1133-1135.
2. (2002b). Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb. Mortal. Wkly. Rep. 51, 877-878.
3. Agrati C., Alonzi T., De S.R., Castilletti C., Abbate I., Capobianchi M.R., et al. (2006a). Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication. Int Immunol. 18, 11-18.
4. Agrati C., Castilletti C., De S.R., Cimini E., Bordi L., Malkovsky M., et al. (2006b). Interferon-gamma-mediated antiviral immunity against orthopoxvirus infection is provided by gamma delta T cells. J. Infect. Dis. 193, 1606-1607.
5. Beasley D.W., Li L., Suderman M.T., Barrett A.D. (2002). Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology. 296, 17-23.
6. Born W.K., Reardon C.L., O'Brien R.L. (2006). The function of gammadelta T cells in innate immunity. Curr. Opin. Immunol. 18, 31-38.
7. Campbell G.L., Marfin A.A., Lanciotti R.S., Gubler D.J. (2002). West Nile virus. Lancet Infect. Dis. 2, 519-529.
8. Carding S.R., Egan P.J. (2002). Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336-345.
9. Charatan F. (2002). Organ transplants and blood transfusions may transmit West Nile virus. BMJ. 325, 566.
10. Chowers M.Y., Lang R., Nassar F., Ben-David D., Giladi M., Rubinshtein E., et al. (2001). Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg. Infect. Dis. 7, 675-678.
11. Cimini E., Piacentini P., Sacchi A., Gioia C., Leone S., Lauro G.M., et al. (2011). Zoledronic acid enhances Vdelta2 T-lymphocyte antitumor response to human glioma cell lines. Int J. Immunopathol. Pharmacol. 24, 139-148.
12. Deniger D.C., Moyes J.S., Cooper L.J. (2014). Clinical applications of gamma delta T cells with multivalent immunity. Front Immunol. 5, 636.
13. Diamond M.S., Shrestha B., Mehlhop E., Sitati E., Engle M. (2003a). Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16, 259-278.
14. Diamond M.S., Sitati E.M., Friend L.D., Higgs S., Shrestha B., Engle M. (2003b). A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198, 1853-1862.
15. Dieli F., Gebbia N., Poccia F., Caccamo N., Montesano C., Fulfaro F., et al. (2003). Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood. 102, 2310-2311.
16. Fang H., Welte T., Zheng X., Chang G.J., Holbrook M.R., Soong L., Wang T. (2010). gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol. Med. Microbiol. 59, 71-80.
17. Hayday A.C. (2000). [gamma] [delta] cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18, 975-1026.
18. Kato Y., Tanaka Y., Tanaka H., Yamashita S., Minato N. (2003). Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate. J. Immunol. 170, 3608-3613.
19. Kramer L.D., Bernard K.A. (2001). West Nile virus infection in birds and mammals. Ann. N.Y. Acad. Sci. 951, 84-93.
20. Kramer L.D., Styer L.M., Ebel G.D. (2008). A global perspective on the epidemiology of West Nile virus. Annu. Rev. Entomol. 53, 61-81.
21. Li H., Xiang Z., Feng T., Li J., Liu Y., Fan Y., et al. (2013). Human Vgamma-9Vdelta2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells. Cell Mol. Immunol. 10, 159-164.
22. Nash D., Mostashari F., Fine A., Miller J., O'Leary D., Murray K., et al. (2001). The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344, 1807-1814.
23. Nedellec S., Bonneville M., Scotet E. (2010). Human Vgamma9Vdelta2 T cells: from signals to functions. Semin. Immunol. 22, 199-206.
24. Poccia F., Agrati C., Castilletti C., Bordi L., Gioia C., Horejsh D., et al. (2006). Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. J. Infect. Dis. 193, 1244-1249.
25. Poccia F., Agrati C., Martini F., Capobianchi M.R., Wallace M., Malkovsky M. (2005a). Antiviral reactivities of gammadelta T cells. Microbes. Infect. 7, 518-528.
26. Poccia F., Agrati C., Martini F., Mejia G., Wallace M., Malkovsky M. (2005b). Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy. Immunol. Lett. 100, 14-20.
27. Poccia F., Battistini L., Cipriani B., Mancino G., Martini F., Gougeon M.L., Colizzi V. (1999). Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J. Infect. Dis. 180, 858-861.
28. Roehrig J.T., Staudinger L.A., Hunt A.R., Mathews J.H., Blair C.D. (2001). Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann. N.Y. Acad. Sci. 951, 286-297.
29. Shrestha B., Samuel M.A., Diamond M.S. (2006a). CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80, 119-129.
30. Shrestha B., Wang T., Samuel M.A., Whitby K., Craft J., Fikrig E., Diamond M.S. (2006b). Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 80, 5338-5348.
31. Sitati E.M., Diamond M.S. (2006). CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80, 12060-12069.
32. Wang T. (2011). Role of gammadelta T cells in West Nile virus-induced encephalitis: friend or foe? J. Neuroimmunol. 240-241, 22-27.
33. Wang T., Gao Y., Scully E., Davis C.T., Anderson J.F., Welte T., et al. (2006). Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. J. Immunol. 177, 1825-1832.
34. Wang T., Scully E., Yin Z., Kim J.H., Wang S., Yan J., et al. (2003). IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 171, 2524-2531.
35. Wang T., Welte T. (2013). Role of natural killer and Gamma-delta T cells in West Nile virus infection. Viruses. 5, 2298-2310.